Related Experiment Videos
[Australia antigen in rheumatoid arthritis]
Allergologia Et Immunopathologia
|November 1, 1976
Summary
Australian antigen (Au Ag) was investigated in 70 rheumatoid arthritis patients using immunoelectrophoresis and radioimmunoassay, yielding negative results. This study contributes to understanding the complex relationship between hepatitis B and rheumatoid arthritis.
Area of Science:
- Hepatology and Immunology
- Rheumatology and Epidemiology
Context:
- Australian antigen (Au Ag), associated with hepatitis B, has been investigated for its potential role in rheumatoid arthritis (RA) due to shared immunopathological mechanisms.
- Previous studies on Au Ag in RA have yielded conflicting results, necessitating further investigation with robust methodologies.
Purpose:
- To investigate the presence of Au Ag in a cohort of 70 patients diagnosed with classical rheumatoid arthritis.
- To compare findings with existing literature and explore reasons for discrepancies in Au Ag detection in RA.
Summary:
- Seventy RA patients were tested for Au Ag using counter immunoelectrophoresis (CIEP) and radioimmunoassay (RIA).
- All 70 patients tested negative for Au Ag. Only four reported a history of possible hepatitis B, with no current clinical or biochemical evidence.
- These findings align with studies reporting negative Au Ag results in RA, contrasting with some reports suggesting a significant presence.
Impact:
- Highlights the need for standardized detection techniques and consideration of antigen's transient nature and geographic distribution in Au Ag research.
- Suggests that factors beyond Au Ag presence, such as surgical history, hospitalizations, and blood transfusions, may influence antigen incidence in chronic conditions like RA.
- Contributes to the ongoing debate regarding the etiological link between hepatitis B and rheumatoid arthritis.